Infective Endocarditis Related to Unusual Microorganisms: A Prospective Population-Based Study.
Candida sp
Cutibacterium acnes
HACEK
Pseudomonas aeruginosa
endocarditis
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
received:
03
02
2020
accepted:
10
04
2020
entrez:
19
5
2020
pubmed:
19
5
2020
medline:
19
5
2020
Statut:
epublish
Résumé
Increased access to heart valves through early surgery and progress in molecular microbiology have reduced the proportion of infective endocarditis (IE) with no microbiological documentation and increased the proportion of IE associated with unusual microorganisms. We performed an ancillary study of a large prospective population-based survey on IE. Unusual-microorganism IE was defined as definite IE (Duke-Li criteria) due to microorganisms other than streptococci, staphylococci, or enterococci. Of 471 cases of documented IE, 46 (9.8%) were due to unusal microorganisms; the following were involved in >1 case: In this population-based study, 9.8% of IE cases were due to unusual microorganisms, with a predominance of anaerobes, yeast, and gram-negative bacilli. As compared with IE related to staphylococci, streptococci, or enterococci, IE cases related to unusual microorganisms were associated with previously known heart disease, prosthetic valve, longer duration of fever, and nosocomial acquisition. ORCID 0000-0003-3617-5411.
Sections du résumé
BACKGROUND
BACKGROUND
Increased access to heart valves through early surgery and progress in molecular microbiology have reduced the proportion of infective endocarditis (IE) with no microbiological documentation and increased the proportion of IE associated with unusual microorganisms.
METHODS
METHODS
We performed an ancillary study of a large prospective population-based survey on IE. Unusual-microorganism IE was defined as definite IE (Duke-Li criteria) due to microorganisms other than streptococci, staphylococci, or enterococci.
RESULTS
RESULTS
Of 471 cases of documented IE, 46 (9.8%) were due to unusal microorganisms; the following were involved in >1 case:
CONCLUSIONS
CONCLUSIONS
In this population-based study, 9.8% of IE cases were due to unusual microorganisms, with a predominance of anaerobes, yeast, and gram-negative bacilli. As compared with IE related to staphylococci, streptococci, or enterococci, IE cases related to unusual microorganisms were associated with previously known heart disease, prosthetic valve, longer duration of fever, and nosocomial acquisition.
TRIAL REGISTRATION
BACKGROUND
ORCID 0000-0003-3617-5411.
Identifiants
pubmed: 32420404
doi: 10.1093/ofid/ofaa127
pii: ofaa127
pmc: PMC7216922
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofaa127Investigateurs
B Hoen
(B)
X Duval
(X)
F Alla
(F)
A Bouvet
(A)
S Briançon
(S)
E Cambau
(E)
M Celard
(M)
C Chirouze
(C)
N Danchin
(N)
T Doco-Lecompte
(T)
F Delahaye
(F)
J Etienne
(J)
B Iung
(B)
V Le Moing
(V)
J F Obadia
(JF)
C Leport
(C)
C Poyart
(C)
M Revest
(M)
C Selton-Suty
(C)
C Strady
(C)
P Tattevin
(P)
F Vandenesch
(F)
Y Bernard
(Y)
S Chocron
(S)
C Chirouze
(C)
B Hoen
(B)
P Plesiat
(P)
I Abouliatim
(I)
C De Place
(C)
P Tattevin
(P)
M Revest
(M)
P Y Donnio
(PY)
F Alla
(F)
J P Carteaux
(JP)
T Doco-Lecompte
(T)
C Lion
(C)
N Aissa
(N)
C Selton-Suty
(C)
B Baehrel
(B)
R Jaussaud
(R)
P Nazeyrollas
(P)
C Strady
(C)
V Vernet
(V)
E Cambau
(E)
X Duval
(X)
B Iung
(B)
P Nataf
(P)
C Chidiac
(C)
M Celard
(M)
F Delahaye
(F)
J F Obadia
(JF)
F Vandenesch
(F)
H Aumaître
(H)
J M Frappier
(JM)
V Le Moing
(V)
E Oziol
(E)
A Sotto
(A)
C Sportouch
(C)
C Poyart
(C)
A Bouvet
(A)
F Vandenesch
(F)
M Celard
(M)
M Bes
(M)
P Abassade
(P)
E Abrial
(E)
C Acar
(C)
N Aissa
(N)
J F Alexandra
(JF)
N Amireche
(N)
D Amrein
(D)
P Andre
(P)
M Appriou
(M)
M A Arnould
(MA)
P Assayag
(P)
A Atoui
(A)
F Aziza
(F)
N Baille
(N)
N Bajolle
(N)
P Battistella
(P)
S Baumard
(S)
A Ben Ali
(A)
J Bertrand
(J)
S Bialek
(S)
M Bois Grosse
(M)
M Boixados
(M)
F Borlot
(F)
A Bouchachi
(A)
O Bouche
(O)
S Bouchemal
(S)
J L Bourdon
(JL)
A Bouvet
(A)
L Brasme
(L)
F Bricaire
(F)
E Brochet
(E)
J F Bruntz
(JF)
A Cady
(A)
J Cailhol
(J)
M P Caplan
(MP)
B Carette
(B)
J P Carteaux
(JP)
O Cartry
(O)
C Cazorla
(C)
M Celard
(M)
H Chamagne
(H)
H Champagne
(H)
G Chanques
(G)
J Chastre
(J)
B Chevalier
(B)
C Chirouze
(C)
F Chometon
(F)
C Christophe
(C)
A Cohen
(A)
N Colin de Verdiere
(N)
N Danchin
(N)
V Daneluzzi
(V)
L David
(L)
P De Lentdecker
(P)
F Delahaye
(F)
V Delcey
(V)
P Deleuze
(P)
E Donal
(E)
X Duval
(X)
B Deroure
(B)
V Descotes-Genon
(V)
K Didier Petit
(K)
A Dinh
(A)
V Doat
(V)
F Duchene
(F)
F Duhoux
(F)
M Dupont
(M)
S Ederhy
(S)
O Epaulard
(O)
M Evest
(M)
J F Faucher
(JF)
B Fantin
(B)
E Fauveau
(E)
T Ferry
(T)
M Fillod
(M)
T Floch
(T)
T Fraisse
(T)
J M Frapier
(JM)
L Freysz
(L)
B Fumery
(B)
B Gachot
(B)
S Gallien
(S)
I Gandjbach
(I)
P Garcon
(P)
A Gaubert
(A)
J L Genoud
(JL)
S Ghiglione
(S)
C Godreuil
(C)
A Grentzinger
(A)
L Groben
(L)
D Gherissi
(D)
P Guéret
(P)
A Hagege
(A)
N Hammoudi
(N)
F Heliot
(F)
P Henry
(P)
S Herson
(S)
B Hoen
(B)
P Houriez
(P)
L Hustache-Mathieu
(L)
O Huttin
(O)
S Imbert
(S)
B Iung
(B)
S Jaureguiberry
(S)
M Kaaki
(M)
A Konate
(A)
J M Kuhn
(JM)
S Kural Menasche
(S)
A Lafitte
(A)
B Lafon
(B)
F Lanternier
(F)
V Le Chenault
(V)
V Le Moing
(V)
C Lechiche
(C)
S Lefèvre-Thibaut
(S)
A Lefort
(A)
A Leguerrier
(A)
J Lemoine
(J)
L Lepage
(L)
C Leport
(C)
C Lepousé
(C)
J Leroy
(J)
P Lesprit
(P)
L Letranchant
(L)
D Loisance
(D)
G Loncar
(G)
C Lorentz
(C)
P Mabo
(P)
I Magnin-Poull
(I)
T May
(T)
A Makinson
(A)
H Man
(H)
M Mansouri
(M)
O Marcxon
(O)
J P Maroni
(JP)
V Masse
(V)
F Maurier
(F)
M C Meyohas
(MC)
P L Michel
(PL)
C Michelet
(C)
F Mechaï
(F)
O Merceron
(O)
D Messika-Zeitoun
(D)
Z Metref
(Z)
V Meyssonnier
(V)
C Mezher
(C)
S Micheli
(S)
M Monsigny
(M)
S Mouly
(S)
B Mourvillier
(B)
O Nallet
(O)
P Nataf
(P)
P Nazeyrollas
(P)
V Noel
(V)
J F Obadia
(JF)
E Oziol
(E)
T Papo
(T)
B Payet
(B)
A Pelletier
(A)
P Perez
(P)
J S Petit
(JS)
F Philippart
(F)
E Piet
(E)
C Plainvert
(C)
B Popovic
(B)
J M Porte
(JM)
P Pradier
(P)
R Ramadan
(R)
M Revest
(M)
J Richemond
(J)
M Rodermann
(M)
M Roncato
(M)
I Roigt
(I)
O Ruyer
(O)
M Saada
(M)
J Schwartz
(J)
C Selton-Suty
(C)
M Simon
(M)
B Simorre
(B)
S Skalli
(S)
F Spatz
(F)
C Strady
(C)
J Sudrial
(J)
L Tartiere
(L)
A Terrier De La Chaise
(A)
M C Thiercelin
(MC)
D Thomas
(D)
M Thomas
(M)
L Toko
(L)
F Tournoux
(F)
A Tristan
(A)
J L Trouillet
(JL)
L Tual
(L)
A Vahanian
(A)
F Verdier
(F)
V Vernet Garnier
(V)
V Vidal
(V)
P Weyne
(P)
M Wolff
(M)
A Wynckel
(A)
N Zannad
(N)
P Y Zinzius
(PY)
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Références
Clin Microbiol Rev. 2001 Jan;14(1):177-207
pubmed: 11148009
Anaerobe. 2017 Oct;47:33-38
pubmed: 28389412
Clin Infect Dis. 2005 Dec 1;41(11):1681-2
pubmed: 16267744
Expert Rev Anti Infect Ther. 2016;14(5):523-30
pubmed: 26953488
Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1203-10
pubmed: 20549531
Med Mal Infect. 2015 Jan-Feb;45(1-2):1-8
pubmed: 25480453
Clin Infect Dis. 2000 Apr;30(4):633-8
pubmed: 10770721
Clin Microbiol Infect. 2017 Jun;23(6):396-399
pubmed: 28057559
Clin Infect Dis. 2010 Jul 15;51(2):131-40
pubmed: 20540619
Medicine (Baltimore). 2017 Nov;96(47):e8392
pubmed: 29381916
Am J Trop Med Hyg. 2015 Apr;92(4):871-4
pubmed: 25646262
Int J Antimicrob Agents. 2014 Oct;44(4):290-4
pubmed: 25178919
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Am Coll Cardiol. 2012 May 29;59(22):1968-76
pubmed: 22624837
Arch Intern Med. 2009 Mar 9;169(5):463-73
pubmed: 19273776
Eur Heart J. 2009 Oct;30(19):2369-413
pubmed: 19713420
PLoS One. 2013 May 17;8(5):e63181
pubmed: 23690995
Medicine (Baltimore). 2005 May;84(3):162-73
pubmed: 15879906
Clin Infect Dis. 2012 May;54(9):1230-9
pubmed: 22492317
Mayo Clin Proc. 1997 Jun;72(6):532-42
pubmed: 9179137
Ann Intern Med. 2007 Dec 18;147(12):829-35
pubmed: 18087053
Ann Thorac Surg. 2015 Jan;99(1):33-7
pubmed: 25442997